290 related articles for article (PubMed ID: 3498440)
1. Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles.
Luderschmidt C; Scholz S; Mehlhaff E; König G; Albert E
Arch Dermatol; 1987 Sep; 123(9):1188-91. PubMed ID: 3498440
[TBL] [Abstract][Full Text] [Related]
2. Lack of an association between diffuse systemic sclerosis and HLA-DR1 or HLA-DR5.
Kratz LE; Boughman JA; Needleman BW
Dis Markers; 1989; 7(4):209-13. PubMed ID: 2573446
[TBL] [Abstract][Full Text] [Related]
3. HLA-DR antigens in progressive systemic sclerosis (scleroderma).
Whiteside TL; Medsger TA; Rodnan GP
J Rheumatol; 1983 Feb; 10(1):128-31. PubMed ID: 6601709
[TBL] [Abstract][Full Text] [Related]
4. Association between DR antigens, rheumatoid arthritis with and without extraarticular features and systemic lupus erythematosus in northern Italy.
Ferraccioli G; Savi M
J Rheumatol; 1988 Jan; 15(1):51-3. PubMed ID: 3258384
[TBL] [Abstract][Full Text] [Related]
5. HLA-antigen frequencies in patients with progressive systemic sclerosis and morphea.
Kühnl P; Sibrowski W; Kalmar G; Holzmann H; Sollberg S; Böhm BO
Beitr Infusionsther; 1990; 26():287-9. PubMed ID: 1703854
[TBL] [Abstract][Full Text] [Related]
6. [Scleroderma and HLA antigens].
Holzmann H; Sollberg S; Schütz K; Kühnl P
Hautarzt; 1989 Mar; 40(3):134-40. PubMed ID: 2714991
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies and immunogenetics in 30 patients with systemic sclerosis and their families.
Pereira S; Black C; Welsh K; Ansell B; Jayson M; Maddison P; Rowell N
J Rheumatol; 1987 Aug; 14(4):760-5. PubMed ID: 3499513
[TBL] [Abstract][Full Text] [Related]
8. Genetic and immunological differences between Japanese patients with diffuse scleroderma and limited scleroderma.
Satoh M; Akizuki M; Kuwana M; Mimori T; Yamagata H; Yoshida S; Homma M; Yamamoto T; Sasazuki T
J Rheumatol; 1994 Jan; 21(1):111-4. PubMed ID: 8151564
[TBL] [Abstract][Full Text] [Related]
9. Strong association between the major histocompatibility complex and systemic lupus erythematosus in southern Chinese.
Hawkins BR; Wong KL; Wong RW; Chan KH; Dunckley H; Serjeantson SW
J Rheumatol; 1987 Dec; 14(6):1128-31. PubMed ID: 3437419
[TBL] [Abstract][Full Text] [Related]
10. HLA antigens, autoantibodies and clinical subsets in scleroderma.
Black CM; Welsh KI; Maddison PJ; Jayson MI; Bernstein RM
Br J Rheumatol; 1984 Nov; 23(4):267-71. PubMed ID: 6593111
[TBL] [Abstract][Full Text] [Related]
11. Histocompatibility antigens in progressive systemic sclerosis (PSS; scleroderma).
Lynch CJ; Singh G; Whiteside TL; Rodnan GP; Medsger TA; Rabin BS
J Clin Immunol; 1982 Oct; 2(4):314-8. PubMed ID: 6982903
[TBL] [Abstract][Full Text] [Related]
12. [HLA-A, B, C phenotype frequencies in progressive systemic scleroderma].
Baldauf C; Schaller J; Herrmann K; Haustein UF
Dermatol Monatsschr; 1989; 175(1):16-9. PubMed ID: 2920860
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of the distribution of class I HLA-antigens in patients with systemic scleroderma with regard to features of the clinical course of the disease and therapy with D-penicillamine].
Pevnitskiĭ LA; Guseva NG; Sibiriakova LG; Oskilko TG
Genetika; 1989 Jun; 25(6):1101-7. PubMed ID: 2806895
[TBL] [Abstract][Full Text] [Related]
14. HLA associations in an Arab type 1 diabetic population.
Behbehani K; Richens ER; Abdella N; Jayyab AK; Shaltout A; Al-Saffar M; Siboo R
Dis Markers; 1987 Sep; 5(3):165-9. PubMed ID: 3502987
[TBL] [Abstract][Full Text] [Related]
15. A strong association between null alleles at the C4A locus in the major histocompatibility complex and systemic sclerosis.
Briggs DC; Welsh K; Pereira RS; Black CM
Arthritis Rheum; 1986 Oct; 29(10):1274-7. PubMed ID: 3490265
[TBL] [Abstract][Full Text] [Related]
16. Molecular heterogeneity of second and fourth components of complement and their genes in systemic sclerosis and association of HLA alleles A1, B8 and DR3 with limited and DR5 with diffuse systemic sclerosis.
Venneker GT; van den Hoogen FH; van Meegen M; de Kok-Nazaruk M; Hulsmans RF; Boerbooms AM; de Waal LP; Bos JD; Asghar SS
Exp Clin Immunogenet; 1998; 15(2):90-9. PubMed ID: 9691203
[TBL] [Abstract][Full Text] [Related]
17. Class II MHC antigen (HLA-DR3) predisposes to sarcoid arthritis.
Krause A; Goebel KM
J Clin Lab Immunol; 1987 Sep; 24(1):25-7. PubMed ID: 3681949
[TBL] [Abstract][Full Text] [Related]
18. Genetic susceptibility to scleroderma-like syndrome in symptomatic and asymptomatic workers exposed to vinyl chloride.
Black C; Pereira S; McWhirter A; Welsh K; Laurent R
J Rheumatol; 1986 Dec; 13(6):1059-62. PubMed ID: 3494121
[TBL] [Abstract][Full Text] [Related]
19. Histocompatibility antigens in progressive systemic sclerosis (scleroderma).
Birnbaum NS; Rodnan GP; Rabin BS; Bassion S
J Rheumatol; 1977; 4(4):425-8. PubMed ID: 604479
[TBL] [Abstract][Full Text] [Related]
20. HLA markers for susceptibility and expression in scleroderma.
Gladman DD; Kung TN; Siannis F; Pellett F; Farewell VT; Lee P
J Rheumatol; 2005 Aug; 32(8):1481-7. PubMed ID: 16078323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
